Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-05-19 16:41:08
Focus: Intratumoral treatment of Basal Cell Carcinoma (BCC) - first-in-class
cancer therapy
The CMD is a live event, open for physical attendance at Hotel Continental in
Oslo, Norway, as well as a live webcast. It starts at 14.00 CET, and is expected
to last approximately two hours, including Q&A.
Speakers will be:
*Øystein Rekdal, CEO of Lytix
- The core of Lytix' Biopharma's technology platform